Cargando…
Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
SIMPLE SUMMARY: Globally, 5q spinal muscular atrophy (SMA) is one of the most common pediatric autosomal recessive neuromuscular diseases, with a prevalence of ~1–2 per 100,000 inhabitants and an incidence of ~1 per 10,000 live births, which makes it the most common cause of infant genetic mortality...
Autores principales: | López-Cortés, Andrés, Echeverría-Garcés, Gabriela, Ramos-Medina, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219894/ https://www.ncbi.nlm.nih.gov/pubmed/35741415 http://dx.doi.org/10.3390/biology11060894 |
Ejemplares similares
-
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019) -
Sm-like proteins in the pathogenesis of Spinal Muscular Atrophy
por: Achsel, Tilmann, et al.
Publicado: (2015) -
miRNA in spinal muscular atrophy pathogenesis and therapy
por: Magri, Francesca, et al.
Publicado: (2017) -
Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018) -
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
por: Sleigh, James N., et al.
Publicado: (2011)